Genovis AB (publ.) (GENO.ST)
SEK 25.0
(2.04%)
SEK 25.0
(2.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 67.75 Million | -927.94 Thousand | 45.91 Million | 3.75 Million | 13.12 Million | -1.24 Million |
| Net Income | 61.5 Million | 8.27 Million | 24.54 Million | 3.14 Million | 10.06 Million | -958.88 Thousand |
| Depreciation & Amortization | 9.72 Million | 6.63 Million | 5.77 Million | 5.43 Million | 3.49 Million | 5.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.38 Million | -14.8 Million | 15.75 Million | -3.82 Million | -3.49 Million | -4.7 Million |
| Other non-cash items | 12.59 Million | -1.03 Million | -151.1 Thousand | -991.44 Thousand | 3.05 Million | -639.83 Thousand |
| Investing Cash Flow | -12.8 Million | -3.82 Million | -4.49 Million | -20.43 Million | -5.15 Million | -1.82 Million |
| Investments in PPE | -12.8 Million | -3.82 Million | -4.49 Million | -20.43 Million | -5.15 Million | -1.82 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.36 Million | -892.99 Thousand | -2.71 Million | 10.00 | -975.39 Thousand | -891.82 Thousand |
| Financing Cash Flow | -4.51 Million | -3.73 Million | -4.23 Million | 45.8 Million | -2.56 Million | 7.74 Million |
| Debt repayment | -4.51 Million | -3.73 Million | -4.23 Million | -3.77 Million | -2.56 Million | -1.7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 49.57 Million | - | 9.44 Million |
| Other Financing Activities | -4.51 Million | -3.73 Million | -4.23 Million | 45.8 Million | -2.56 Million | -1.7 Million |
| Accounts receivables | -8.7 Million | -14.34 Million | 884.05 Thousand | -5.29 Million | -2.31 Million | -2.24 Million |
| Accounts payables | 14.43 Million | -320.32 Thousand | 14.4 Million | 5.38 Million | 2.04 Million | 111.14 Thousand |
| Inventory | -2.34 Million | -138.41 Thousand | 465.84 Thousand | -3.91 Million | -3.22 Million | -2.57 Million |
| Other working capital | 3.38 Million | - | - | - | - | -2.13 Million |
| Cash at beginning of period | 72.83 Million | 81.31 Million | 44.11 Million | 14.99 Million | 9.58 Million | 4.91 Million |
| Cash at end of period | 123.26 Million | 72.83 Million | 81.31 Million | 44.11 Million | 14.99 Million | 9.58 Million |
| Capital Expenditure | -12.8 Million | -3.82 Million | -4.49 Million | -20.43 Million | -5.15 Million | -1.82 Million |
| Effect of forex changes on cash | -140.00 | - | - | -10.00 | - | - |
| Net cash flow / Change in cash | 50.43 Million | -8.48 Million | 37.19 Million | 29.12 Million | 5.41 Million | 4.66 Million |
| Free Cash Flow | 54.94 Million | -4.75 Million | 41.42 Million | -16.67 Million | 7.97 Million | -3.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.79 Million | 12.74 Million | 61.5 Million | -422 Thousand | 4.48 Million | 5.98 Million |
| Depreciation & Amortization | 2.75 Million | 2.73 Million | 9.72 Million | 3.26 Million | 3.06 Million | 1.7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.74 Million | -611 Thousand | 3.38 Million | 6.38 Million | 2.27 Million | -6.4 Million |
| Other non-cash items | 6.41 Million | 8.69 Million | 12.59 Million | 7.17 Million | -219 Thousand | 636 Thousand |
| Investing Cash Flow | -1.7 Million | -1.09 Million | -12.8 Million | -2.21 Million | 4.76 Million | -3.98 Million |
| Investments in PPE | - | -329 Thousand | -12.8 Million | -1.42 Million | -4.23 Million | -3.35 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.7 Million | -1.09 Million | -2.36 Million | -790 Thousand | 8.99 Million | -634 Thousand |
| Financing Cash Flow | 1.01 Million | -3.46 Million | -4.51 Million | -3.52 Million | 172 Thousand | 872 Thousand |
| Debt repayment | - | - | -4.51 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.01 Million | -3.46 Million | -4.51 Million | -3.52 Million | 172 Thousand | 872 Thousand |
| Accounts receivables | - | - | -8.7 Million | -8.7 Million | - | - |
| Accounts payables | - | - | 14.43 Million | - | - | - |
| Inventory | - | - | -2.34 Million | -2.34 Million | - | - |
| Other working capital | -5.74 Million | -611 Thousand | 3.38 Million | 6.38 Million | 2.27 Million | -6.4 Million |
| Cash at beginning of period | 136.79 Million | 123.26 Million | 72.83 Million | 119.13 Million | 114.19 Million | 115.39 Million |
| Cash at end of period | 135.8 Million | 136.79 Million | 123.26 Million | 123.26 Million | 119.13 Million | 114.19 Million |
| Capital Expenditure | - | -329 Thousand | -12.8 Million | -1.42 Million | -4.23 Million | -3.35 Million |
| Effect of forex changes on cash | - | - | -140.00 | - | -9.61 Million | - |
| Net cash flow / Change in cash | -984 Thousand | 13.53 Million | 50.43 Million | 4.13 Million | 4.93 Million | -1.19 Million |
| Free Cash Flow | -295 Thousand | 17.76 Million | 54.94 Million | 8.44 Million | 5.37 Million | -1.43 Million |
AKBA
ALJXR
POAHY
6820
0LJB
AOLS